Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

NCT02836847 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma of the Extrahepatic Bile Duct
Gallbladder Cancer

Interventions

PROCEDURE: biological test
DRUG: GEMOX
DRUG: Cetuximab
DRUG: Trastuzumab
DRUG: Gefitinib
DRUG: Lapatinib
DRUG: Everolimus
DRUG: Sorafenib
DRUG: Crizotinib

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]